Baseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica
Clinical Rheumatology · 2026-11 · 45 (11) · 7081-7087
DOI: 10.1007/s10067-026-08403-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Rheumatology, online erschienen am 10.09.2026. Verfasst von Ciro Manzo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal and Geriatric Medicine Department, Regional Health Authority, South Naples 3, Naples, Italy. manzoreumatologo@libero.it. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Glucocorticoids. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Glucocorticoids remain the cornerstone of polymyalgia rheumatica (PMR) management, but prolonged use carries significant toxicity risks in older adults. Despite high multi-morbidity prevalence, systematic screening using validated geriatric scales is rarely performed. We evaluated whether baseline systemic comorbidity burden, quantified via the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), is associated with persistent glucocorticoid utilization at 12 months. In this perspective report of 154 older outpatients (mean age 71.74 years) with isolated PMR, baseline comorbidity density maintained a significant exploratory association with 12-month persistent glucocorticoid requirements (adjusted OR 1.11, 95% CI 1.05–1.16; P 25, P < 0.001). A scales-based comorbidity assessment offers a practical operationalization of the 2024 EULAR/ACR Treat-to-Target recommendations, optimizing baseline risk stratification during weaning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal and Geriatric Medicine Department, Regional Health Authority, South Naples 3, Naples, Italy. manzoreumatologo@libero.it.
- Department of Primary Care, Health District of Soverato, Azienda Sanitaria Provinciale , Catanzaro, Italy.
Zitieren
APA
Manzo, C., & Castagna, A. (2026). Baseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica. Clinical Rheumatology, 45(11), 7081-7087. https://doi.org/10.1007/s10067-026-08403-5
Vancouver
Manzo C, Castagna A. Baseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica. Clinical Rheumatology. 2026;45(11):7081-7087. doi:10.1007/s10067-026-08403-5
BibTeX
@article{Manzo2026,
author = {Manzo, Ciro and Castagna, Alberto},
title = {Baseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {11},
pages = {7081--7087},
doi = {10.1007/s10067-026-08403-5}
}
EUVIMED